{"title":"Effectiveness of Artificial Intelligence-Assisted Colposcopy in a Resource-Limited Population.","authors":"Yining Chang,Tingyuan Li,Qiang Zhou,Dianju Kang,Lingling Zhu,Jingjing Yang,Qiongxiu Kou,Huijuan He,Yulin Zhou,Qiong Liao,Jingchang Du,Xiaoping Yu,Yuqian Zhao","doi":"10.1097/aog.0000000000006014","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nThis study evaluates the performance of artificial intelligence (AI) colposcopy in detecting cervical cancer and precancerous lesions in real-world scenarios within resource-limited areas.\r\n\r\nMETHODS\r\nThis is a cross-sectional study. Participants with positive human papilloma virus results or who were cytologic positive were referred for colposcopy, during which AI colposcopy was implemented. Biopsies were performed for positive findings suggested by either the colposcopist or the AI system. For the analysis, we calculated the sensitivity, specificity, positive predictive value, negative predictive value, and area under the curve for detecting cervical intraepithelial neoplasia (CIN) 2+ and CIN 3+. Histopathology was the gold standard for disease diagnosis.\r\n\r\nRESULTS\r\nA total of 825 women underwent colposcopy, with 99 (12.0%) diagnosed with CIN 2+ and 53 (6.4%) with CIN 3+. Positive findings were reported in 392 women (47.5%) under conventional colposcopy and 640 (77.6%) with AI colposcopy. The sensitivity for detecting CIN 2+ was significantly higher for AI colposcopy (96.0%) and AI-assisted colposcopy (100%) than for conventional colposcopy (85.9%, P=.026, P<.001, respectively). In postmenopausal women, the sensitivities of AI colposcopy (94.3%) and AI-assisted colposcopy (100%) surpassed that of conventional colposcopy (77.4%, P=.026, P<.001, respectively). Artificial intelligence-assisted colposcopy also significantly enhanced the sensitivity of junior colposcopists with less than 10 years of clinical experience, achieving 100% compared with 84.6% by conventional colposcopy (P=.001), and improved detection in women with a squamocolumnar junction that was not visible (100% vs 70.4%, P=.004). For CIN 3+, the sensitivity of AI-assisted colposcopy was superior to that of conventional colposcopy (100% vs 86.8%, P=.013). In postmenopausal women, the sensitivities of both AI colposcopy and AI-assisted colposcopy were 100%; however, the sensitivity of conventional colposcopy was 77.8% (P=.023).\r\n\r\nCONCLUSION\r\nArtificial intelligence-assisted colposcopy enhances sensitivity in detecting CIN 2+ and CIN 3+, particularly among postmenopausal women. Moreover, it improves the diagnostic performance of junior colposcopists and improves detection in women with a squamocolumnar junction that is not visible.","PeriodicalId":19483,"journal":{"name":"Obstetrics and gynecology","volume":"29 1","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics and gynecology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/aog.0000000000006014","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
OBJECTIVE
This study evaluates the performance of artificial intelligence (AI) colposcopy in detecting cervical cancer and precancerous lesions in real-world scenarios within resource-limited areas.
METHODS
This is a cross-sectional study. Participants with positive human papilloma virus results or who were cytologic positive were referred for colposcopy, during which AI colposcopy was implemented. Biopsies were performed for positive findings suggested by either the colposcopist or the AI system. For the analysis, we calculated the sensitivity, specificity, positive predictive value, negative predictive value, and area under the curve for detecting cervical intraepithelial neoplasia (CIN) 2+ and CIN 3+. Histopathology was the gold standard for disease diagnosis.
RESULTS
A total of 825 women underwent colposcopy, with 99 (12.0%) diagnosed with CIN 2+ and 53 (6.4%) with CIN 3+. Positive findings were reported in 392 women (47.5%) under conventional colposcopy and 640 (77.6%) with AI colposcopy. The sensitivity for detecting CIN 2+ was significantly higher for AI colposcopy (96.0%) and AI-assisted colposcopy (100%) than for conventional colposcopy (85.9%, P=.026, P<.001, respectively). In postmenopausal women, the sensitivities of AI colposcopy (94.3%) and AI-assisted colposcopy (100%) surpassed that of conventional colposcopy (77.4%, P=.026, P<.001, respectively). Artificial intelligence-assisted colposcopy also significantly enhanced the sensitivity of junior colposcopists with less than 10 years of clinical experience, achieving 100% compared with 84.6% by conventional colposcopy (P=.001), and improved detection in women with a squamocolumnar junction that was not visible (100% vs 70.4%, P=.004). For CIN 3+, the sensitivity of AI-assisted colposcopy was superior to that of conventional colposcopy (100% vs 86.8%, P=.013). In postmenopausal women, the sensitivities of both AI colposcopy and AI-assisted colposcopy were 100%; however, the sensitivity of conventional colposcopy was 77.8% (P=.023).
CONCLUSION
Artificial intelligence-assisted colposcopy enhances sensitivity in detecting CIN 2+ and CIN 3+, particularly among postmenopausal women. Moreover, it improves the diagnostic performance of junior colposcopists and improves detection in women with a squamocolumnar junction that is not visible.
期刊介绍:
"Obstetrics & Gynecology," affectionately known as "The Green Journal," is the official publication of the American College of Obstetricians and Gynecologists (ACOG). Since its inception in 1953, the journal has been dedicated to advancing the clinical practice of obstetrics and gynecology, as well as related fields. The journal's mission is to promote excellence in these areas by publishing a diverse range of articles that cover translational and clinical topics.
"Obstetrics & Gynecology" provides a platform for the dissemination of evidence-based research, clinical guidelines, and expert opinions that are essential for the continuous improvement of women's health care. The journal's content is designed to inform and educate obstetricians, gynecologists, and other healthcare professionals, ensuring that they stay abreast of the latest developments and best practices in their field.